Abstract
Perhaps as many as 25–50% of adult patients and children with acquired immunodeficiency syndrome (AIDS) eventually suffer from neurological manifestations, including dysfunction of cognition, movement, and sensation. How can human immunodeficiency virus type 1 (HIV-1) result in neuronal damage if neurons themselves are for all intents and purposes not infected by the virus? this article reviews a series of experiments leading to a hypothesis that accounts at least in part for the neurotoxicity observed in the brains of AIDS patients. There is growing support for the existence of HIV- or immune-related toxins that lead indirectly to the injury or demise of neurons via a potentially complex web of interactions among macrophages (or microglia), astrocytes, and neurons. HIV-infected monocytoid cells (macrophages, microglia, or monocytes), after interacting with astrocytes, secrete eicosanoids, i.e., arachidonic acid and its metabolites, including platelet-activating factor. Macrophages activated by HIV-1 envelope protein gp 120 also appear to release arachidonic acid and its metabolites. In addition, interferon-γ (IFN-γ) stimulation of macrophages induces release of the glutamate-like agonist, quinolinate. Furthermore, HIV-infected macrophage production of cytokines, including TNF-α and IL1-β, contributes to astrogliosis. A final common pathway for neuronal susceptibility appears to be operative, similar to that observed in stroke, trauma, epilepsy, neuropathic pain, and several neurodegenerative diseases, possibly including Huntington's disease, Parkinson's disease, and amyotrophic lateral sclerosis. This mechanism involves the activation of voltage-dependent Ca2+ channels andN-methyl-d-aspartate (NMDA) receptor-operated channels, and, therefore, offers hope for future pharmacological intervention. This article focuses on clinically tolerated calcium channel antagonists and NMDA antagonists with the potential for trials in humans with AIDS dementia in the near future.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Lipton S. A. and Kater S. B. (1989)Trends Neurosci. 12, 265–270.
Choi D. W. (1988)Neuron 1, 623–634.
Meldrum B. and Garthwaite J. (1990)Trends Pharmacol. Sci. 11, 379–387.
Lipton S. A. and Rosenberg P. A. (1994)New Engl. J. Med. 330, 613–622.
Miller R. J. (1991)Prog. Neurobiol. 37, 255–285.
Lipton S. A. (1991)Adv. Pharmacol. 22, 271–291.
Price R. W., Brew B., Sidtis J., Rosenblum M., Scheck A. C., and Cleary P. (1988)Science 239, 586–592.
Epstein L. G. and Gendelman H. E. (1993)Ann. Neurol. 33, 429–436.
Ketzler S., Weis S., Haug H., and Budka H. (1990)Acta Neuropathol. (Berlin) 80, 90–92.
Wiley C. A., Masliah E., Morey M., Lemer C., DeTerasa R. M., Grafe M. R., Hansen L. A., and Terry R. D. (1991)Ann. Neurol. 29, 651–657.
Evarall I. P., Luthbert P. J., and Lantos P. L. (1991)Lancet 337, 1119–1121.
Tenhula W. N., Xu S. Z., Madigan M. C., Heller K., Freeman W. R., and Sadun A. A. (1992).Am. J. Ophthalmol. 113, 14–20.
Masliah E., Achim C. L., Ge N., De Teresa R., Terry R. D., and Wiley C. A. (1992)Ann. Neurol. 32, 321–329.
Brenneman D. E., Westbrook G. L., Fitzgerald S. P., Ennist D. L., Elkins K. L., Ruff M., and Pert C. B. (1988)Nature 335, 639–642.
Dreyer E. B., Kaiser P. K., Offermann J. T., and Lipton S. A. (1990)Science 248, 364–367.
Lo T.-M., Fallert C. J., Piser T. M., and Thayer S. A. (1992)Brain Res. 594, 189–196.
Müller W. E. G., Schröder H. C., Ushijima H., Drapper J., and Bormann J. (1992)Eur. J. Pharmacol.—Mol. Pharmacol. Sect. 226, 209–214.
Dawson V. L., Dawson T. M., Uhl G. R., and Snyder S. H. (1993)Proc. Natl. Acad. Sci. USA 90, 3256–3259.
Savio T. and Levi G. (1993)J. Neurosci. Res. 34, 265–272.
Lipton S. A. (1991)Ann. Neurol. 30, p110–114.
Lipton S. A. and Jensen F. E. (1992)Soc. Neurosci. Abstr. 18, 757.
Mervis R. F., Hill J. M., and Brenneman D. E. (1990)Int. Conf. AIDS 6, 184.
Glowa J. R., Panlilio L. V., Brenneman D. E., Gozes I., Fridkin M., and Hill J. M. (1992)Brain Res. 570, 49–53.
Buzy J., Brenneman D. E., Pert C. B., Martin A., Salazar A., and Ruff M. R. (1992)Brain Res. 598, 10–18.
Abele A. E., Scholz K. P., Scholz W. K., and Miller R. J. (1990)Neuron 4, 413–419.
Weiss J. H., Hartley D. M., Koh J., and Choi D. W. (1990)Science 247, 1474–1477.
Sucher N. J., Lei S. Z., and Lipton S. A. (1991)Brain Res. 551, 297–302.
Heyes M. P., Rubinow D., Lane C., and Markey S. P. (1989)Ann. Neurol. 26, 275–277.
Heyes M. P., Brew B. J., Martin A., Price R. W., Salazqr A. M., Sidtis J. J., Yergey J. A., Mouradian M. M., Sadler A., Keilp J., Rubinow D., and Markey S. P. (1991)Ann. Neurol. 29, 202–209.
Lipton S. A., Kaiser P. K., Sucher N. J., Dreyer E. B., and Offermann J. T. (1990)Soc. Neurosci. Abstr. 16, 289.
Lipton S. A., Sucher N. J., Kaiser P. K., and Dreyer E. B. (1991)Neuron 7, 111–118.
Mattson M. P., Lee R. E., Adams M. E., Guthrie P. B., and Kater S. B. (1988)Neuron 1, 865–876.
Offermann J., Uchida K., and Lipton S. A. (1991)Soc. Neurosci. Abstr. 17, 927.
Sweetnam P. M., Saab O. H., Wroblewski J. T., Price C. H., Larbon W., and Ferkany J. W. (1993)Eur. J. Neurosci. 5, 276–283.
Lipton S. A. (1992)NeuroReport 3, 913–915.
Gelman B. G. (1993)Ann. Neurol. 34, 65–70.
Kaiser P. K., Offermann J. T., and Lipton S. A. (1990)Neurology 40, 1757–1761.
Giulian D., Wendt E., Vaca K., and Noonan C. A., (1993)Proc. Natl. Acad. Sci. USA 90, 2769–2773.
Giulian D., Vaca K., and Noonan C. A. (1990)Science 250, 1593–1596.
Pulliam L., Herndler B. G., Tang N. M., and McGrath M. S. (1991)J. Clin. Invest. 87, 503–512.
Genis P., Jett M., Berton E. W., Boyle T., Gelbard H. A., Dzenko K., Keane R. W., Resnick L., Mizrachi T., Volsky D. J., Epstein L. G., and Gendelman H. E. (1992)J. Exp. Med. 176, 1703–1718.
Selmaj K. N., Farooq M., Norton T., Raine C. S., and Brosman C. F. (1990)J. Immunol. 144, 129–135.
Chung I. Y. and Benveniste E. N. (1990)J. Immunol. 144, 2999–3007.
Vitkovic L., Kalebic T., de Cunha A., and Fauci A. S. (1990)J. Neuroimmunol. 30, 153–160.
Robbins D. S., Shirazi T., Drysdale B. E., Beiberman A., Shin H. S., and Shin M. L. (1987)J. Immunol. 139, 2593–2597.
Morganati-Kossmann M. C., Kossmann T., and Wahl S. M. (1992).Trends Pharmacol. Sci. 13, 286–290.
Conti P., Reale M., Barbacane R. C., Bongrazia M., Panara M. R., and Fiore S. (1989) inProstaglandins in Clinical Research: Cardiovascular System (Conti P., Reale M., Barbacane R. C., Bongrazia M., Panara M. R., and Riore S., eds.), Liss, New York.
Dubois C., Bissonnette E., and Rola-Pleszczynski M. (1989)J. Immunol. 143, 964–970.
Poubelle P. E., Gingras D., Demers C., Dubois C., Harbour D., Grassi J., and Rola-Pleszczynski M. (1991)Immunology 72, 181–187.
Pignol P., Sylvie H., Mencia-Huerta J.-M., and Rola-Pleszczynski M. (1987)Prostaglandins 33, 931–939.
Valone F. H., Philip R., and Debs R. J. (1988)Immunology 64, 715–718.
Valone F. H. and Epstein L. B. (1988)J. Immunol. 141, 3945–3950.
Wahl L. M., Corcoran M. L., Pyle S. W., Arthur L. O., Harel-Bellan A., and Farrar W. L. (1989)Proc. Natl. Acad. Sci. USA 86, 621–625.
Merrill J. E., Koyanagi Y., and Chen I. S. Y. (1989)J. Virol. 63, 4404–4408.
Merrill J. E. and Chen I. S. Y. (1991)FASEB J. 5, 2391–2397.
Bito H., Nakamura M., Honda Z., Isumi T., Twatsubo T., Seyama T., Sgura A., Kido Y., and Schimizu T. (1992)Neuron 9, 285–294.
Marcheselli V. L. and Bazan N. G. (1993)Invest. Ophthalmol. Vis. Sci. 34, 1048.
Clark G. D., Happel L. T., Zorumski C. F., and Bazan N. G. (1992)Neuron 9, 1211–1216.
Soliven B. and Albert J. (1992)J. Neurosci. 12, 2665–2671.
Zhang D., Choi Y.-B., Offermann J., Gendelman H. E., and Lipton S. A. (1993)Soc. Neurosci. Abstr. 19, 1502.
Gelbard H. A., Nottet H. S. L. M., Swindells S., Jett M., Dzenkok A., Genis P., et al. (1994)J. Virol., in press.
Wieraszko A., Li G. Dornecki E., Hogan M. V., and Ehrlich Y. H. (1993)Neuron 10, 553–557.
Volterra A., Trotti D., Cassutti P., Tromba C., Salvaggio A., Melcangi R. C., and Racagni G. (1992)J. Neurochem. 59, 600–606.
Miller B., Sarantis M., Traynelis S. F., and Attwell D. (1992)Nature 355, 722–725.
Lipton S. A. (1992)Trends Neurosci. 15, 75–79.
Tyor W. R., Glass J. D., Griffin J. W., Becker S., McArthur J. C., Bezman L., and Griffin D. E. (1992)Ann. Neurol. 31, 349–360.
Heyes M. P., Saito K., and Markey S. P. (1992)Biochem. J. 283, 633–635.
Speciale C., Okuno E., and Schwarz R. (1987)Brain Res. 436, 18–24.
Kohler C., Eriksson L. G., Okuno E., and Schwarz R. (1988)Neuroscience 27, 49–76.
Brenneman D. E., Nicol T., Warren D., and Bowers L. M. (1990)J. Neurosci. Res. 25, 386–394.
Giulian D., Vaca K., and Corpuz M. (1993)J. Neurosci. 13, 29–37.
Harouse J. M., Bhat S., Spitalnik S. L., Laughlin M., Stefano K., Silberberg D. H., and Gonzalez-Scarano F. (1991)Science 253, 320–323.
Bhat S., Spitalnik S. L., Gonzalez-Scarano F., and Silberberg D. H. (1991)Proc. Natl. Acad. Sci. USA 88, 7131–7134.
van den Berg L. H., Sadiq S. A., Lederman S., and Latov N. (1992)J. Neurosci. Res. 33, 513–518.
Latov N., Apostolski S., Quattrini A., Lavasta J., Lugaresi A., McAlarney T., Sadiq S. A., and Hays A. P. (1993)Neurology 43, A384.
Levi G., Patrizio M., Bernardo A., Petrucci T. C., and Agresti C. (1993)Proc. Natl. Acad. Sci. USA 90, 1541–1545.
Gourdou I., Mabrouk K., Harkiss G., Marchot P., Watt N., Hery F., and Vigne R. (1990).C.r. hebd Séanc Acad. Sci. Paris 311 (Series III), 149–155.
Sabatier J.-M., Vives E., Mabrouk K., Benjouad A., Rochat H., Duval A., Jue B., and Bahraoui E. (1991)J. Virol. 65, 961–967.
Haykman M., Arbuthnott G., Harkiss G., Brace H., Filippi P., Philippon V., Thompson D., Vigne R., and Wright A. (1993)Neuroscience 53, 1–6.
Werner T., Feroni S., Saermark T., Brack-Werner R., Banati R. B., Mayer R., Steinaa L., Kreutzberg G. W., and Erfle V. (1991)AIDS 5, 1301–1308.
Tardieu M., Héry C., Peudenier S., Boesflug O., and Montagnier L. (1992)Ann. Neurol. 32, 11–17.
Lipton S. A. (1993)Ann. Neurol. 33, 227–228.
Lipton S. A. (1992)Neurology 42, 1403–1405.
Dawson V. L., Dawson T. M., Uhl G. R., and Snyder S. H. (1992)Soc. Neurosci. Abstr. 18, 756.
Karschin A., Aizenman E., and Lipton S. A. (1988)J. Neurosci. 8, 2895–2906.
Levy D. I. and Lipton S. A. (1990)Neurology 40, 852–855.
Chen H.-S. V., Pellegrini J. W., Aggarwal S. K., Lei S. Z., Warach S., Jensen F. E., and Lipton S. A. (1992)J. Neurosci. 12, 4427–4436.
Koek W., Woods J. H., and Winger G. D. (1988)J. Pharmacol. Exp. Ther. 245, 969–974.
Olney J. W., Labruyere J., and Price M. T. (1989)Science 244, 1360–1362.
MacDonald J. F., Miljkovic Z., and Pennefather P. (1987)J. Neurophysiol. 58, 251–266.
Davies S. N., Alford S. T., Coan E. J., Lester R. A., and Collingridge G. L. (1988)Neurosci. Lett. 92, 213–217.
O'Shaughnessy C. T. and Lodge D. (1988)Eur. J. Pharmacol. 153, 201–209.
Choi D. W. (1987)Brain Res. 403, 333–336.
Choi D. W., Peters S., and Viseskul V. (1987)J. Pharmacol. Exp. Ther. 242, 713–720.
Rogawski M. A. and Porter R. J. (1990)Pharmacol. Rev. 42, 223–286.
Toggas S. M., Masliah E., Rockenstein E. M., Rall G. F., Abraham G. R., and Mucke L. (1994)Nature 367, 188–193.
Bormann J. (1989)Eur. J. Pharmacol. 166, 591–592.
Goldman R. S. and Finkbeiner S. M. (1988)N. Engl. J. Med. 319, 1224–1225.
Wolf G., Keilhoff G., Fischer S., and Hass P. (1990)Neurosci. Lett. 117, 207–211.
Wolf G., Fischer S., Hass P., Abicht K., and Keilhoff G. (1991)Neuroscience 43, 31–34.
Zeevalk G. D. and Nicklas W. J. (1992)J. Neurochem. 59, 1211–1220.
Aizenman E., Lipton S. A., and Loring R. H. (1989)Neuron 2, 1257–1263.
Tang L. H. and Aizenman E. (1993)J. Physiol. 465, 303–323.
Sucher N. J., Wong L. A., and Lipton S. A. (1990)NeuroReport 1, 29–32.
Reynolds I. J., Rush E. A., and Aizenman E. (1990)Br. J. Pharmacol. 101, 178–182.
Levy D. E., Sucher N. J., and Lipton S. A. (1990)Neurosci. Lett. 110, 291–296.
Aizenman E. and Hartnett K. A. (1992)Brain Res. 585, 28–34.
Aizenman E., Hartnett K. A., and Reynolds I. J., (1990)Neuron 5, 841–846.
Lei S. Z., Pan Z. H., Aggarwal S. K., Chen H. S., Hartman J., Sucher N. J., and Lipton S. A. (1992)Neuron 8, 1087–1099.
Stamler J. S., Singel D. J., and Loscalzo J. (1992)Science 258, 1898–1902.
Beckman J. S., Beckman T. W., Chen J., Marshall P. A., and Freeman B. A. (1990)Proc. Natl. Acad. Sci. USA 87, 1620–1624.
Radi R., Beckman J. S., Bush K. M., and Freeman B. A. (1991)J. Biol. Chem. 226, 4244–4250.
Dawson V. L., Dawson T. M., London E. D., Bredt D. S., and Snyder S. H. (1991)Proc. Natl. Acad. Sci. USA 88, 6368–6371.
Dawson T. M., Dawson V. L., and Snyder S. H. (1992)Ann. Neurol. 32, 297–311.
Lipton S. A., Choi Y.-B., Pan Z.-H., Lei S. Z., Chen V. H.-S., Sucher N. J., Loscalzo J., Singel D. J., and Stamler J. S. (1993)Nature 364, 626–632.
Manchester K. S., Jensen F. E., Warach S., and Lipton S. A. (1993)Neurology 43, A365.
Levy D. E., Sucher N. J., and Lipton S. A. (1991)NeuroReport 2, 345–347.
Sucher N. J., and Lipton S. A. (1991)J. Neurosci. Res. 30, 582–591.
Gilbert K. R., Aizenman E., and Reynolds I. J. (1991)Neurosci. Lett. 133, 11–14.
Aizenman E., Hartnett K. A., Zhon C., Gallop P. M., and Rosenberg P. A. (1992)J. Neurosci. 12, 2362–2369.
Regan L. J., Sah D. W. Y., and Bean B. P. (1991)Neuron 6, 269–280.
Carpenter C. L., Marks S. S., Watson D. L., and Greenberg D. A. (1988)Brain Res. 439, 372–375.
Uematsu D., Araki N., Greenberg J. H., Sladky J., and Reivich M. (1991)Neurology 41, 372–375.
Rod M. R. and Auer R. N. (1992)Stroke 23, 725–732.
Hewitt K. and Corbett D. (1992)Stroke 23, 82–86.
Rocca W. A., Dorsey F. C., Grigoletto F., Gent M., Roberts R. S., Walker M. D., Easton J. D., Bruno R., Carolei A., Sancesario G., and Fieschi C. (1992)Stroke 23, 519–526.
Figueras A., Morales-Olivas F. J., Capella D., Palop V., and Laporte J. R. (1992)Br. Med. J. 305, 1330,1331.
Raschetti R., Maggini M., and Popoli P. (1992)Lancet 340 60.
Wesemann W., Sturn G., and Fünfgeld E. W. (1980)J. Neural. Trans. (Suppl.),16, 143–148.
Seif el Nasr M., Perucher B., Rossberg C., Mennel H.-D., and Krieglstein J. (1990)Eur. J. Pharmacol. 185, 19–24.
Erdö S. L. and Schäfer M. (1991)Eur. J. Pharmacol. 198, 215–217.
Keilhoff G. and Wold G. (1992)Eur. J. Pharmacol. 219, 415–454.
Osborne N. N. and Quack G. (1992)Neurochem. Int. 21, 329–336.
Lipton S. A. (1994)Nature 367, 113,114.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lipton, S.A. HIV-related neuronal injury. Mol Neurobiol 8, 181–196 (1994). https://doi.org/10.1007/BF02780669
Issue Date:
DOI: https://doi.org/10.1007/BF02780669